If the acquisition proceeds (which seems likely) $600k will...

If the acquisition proceeds (which seems likely) $600k will leave the coffers in February, but it’s possible that will be the limit of any cash depletion, because (and please correct me if I’m wrong) it is my recollection that one of the successful resolutions at the AGM was a provision to pay out the balance of the EGP Capital loan in scrip. If that’s correct, I presume the provision wouldn’t have been put to shareholders if EGP was not agreeable to the proposition.

Now it may well be that some shareholders may want to get hot under the collar about the dilutionary impact of paying out EGP in scrip and, for that matter funding part of the acquisition of 3CT through a scrip allocation, but it seems like a more palatable option than the sort of cash depletion you have otherwise foreshadowed as being impending.

zeno9